Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).

Author: Khera, Amit V. MD *; Demler, Olga V. PhD *; Adelman, Steven J. PhD; Collins, Heidi L. PhD; Glynn, Robert J. PhD; Ridker, Paul M MD, MPH; Rader, Daniel J. MD; Mora, Samia MD, MHS

Page: 2494-2504

http://ift.tt/2rxPK4s